Spire Wealth Management Cassava Sciences Inc Transaction History
Spire Wealth Management
- $3.01 Billion
- Q1 2024
A detailed history of Spire Wealth Management transactions in Cassava Sciences Inc stock. As of the latest transaction made, Spire Wealth Management holds 30 shares of SAVA stock, worth $370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$370
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
172Shares Held
11.3MCall Options Held
1.61MPut Options Held
1.43M-
Black Rock Inc. New York, NY3.05MShares$37.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$29.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.09MShares$13.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA902KShares$11.1 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO585KShares$7.23 Million6.03% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $495M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...